Selection of optimal first-line immuno-related therapy based on specific pathological characteristics for patients with advanced driver-gene wild-type non-small cell lung cancer: a systematic review and network meta-analysis:
2021
Background:Although immune checkpoint inhibitors (ICIs) have improved survival for advanced wild-type non-small cell lung cancer (NSCLC), a lack of direct comparisons of various first-line treatmen...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
54
References
1
Citations
NaN
KQI